दिल्ली के नेहरू होम्योपैथिक मेडिकल कालेज और इस प्रोजेक्ट से जुडे चिकित्सक/प्रोजेक्ट अधिकारी से अनुरोध है कि अगर वह इस ब्लाग से गुजर रहे हों तो नवीनतम जानकारी देने की कृपा करें और साथ ही मे दिल्ली अनुसंधान की साइट को भी अपडेट करने की कृपा करें ।
Clinical Research in Tuberculosis/MDRTB
The research was being undertaken at the following three centres.
Nehru Homoeopathic Medical College and Hospital – July 2000
Nehru Nagar TB Chest Clinic – February 2001
Gulabi Bagh Chest Clinic – January 2003
Staff engaged in the project
Project Guide
Dr. K. K. Goyal, MBBS
Dr. Kusum Chand, MBBS, MD, MF (Hom)
Consultants
Dr. Sandhya Madan, Pathologist, NHMC & H
Dr. Indira De, Radiologist, NHMC & H
Core Group
Dr. Jugal Kishore, Chairman, SAC
Dr. J. N. Banvalikar, TB Programme Officer, MCD
Dr. V. K. Khanna, Principal, NHMC
Dr. R. K. Manchanda, Member Secretary
Research Staff
a) Dr. Surender Verma, Assistant Director (H)
b) Dr. Sudhir Batra, Medical Officer (H)
c)Senior Research Fellows (Homoeopathy)
*
Dr. Renu Mittal
Laboratory Support
Nehru Homoeopathic Medical College and Hospital
* Haemogram and Blood Tests
* Sputum for AFB
* X- Ray
* HIV testing and other biochemistry tests
New Delhi Tuberculosis Centre
* Sputum Culture
* Sputum for AFB
I. Nehru Nagar TB Center
The Nehru Nagar TB center was started in Feb.2001 to carry out clinical research on multi-drug resistant tuberculosis. A total of 120 patients of CAT-II failure were treated and useful homeopathic drugs were identified for undertaking Double Blind Placebo Control trial according to the protocol.
II. Nehru Homoeopathic Medical College and Hospital
During this year, out of the total of 66 patients, 24 cases followed-up regularly. [CAT-II failure 15, lymphadenitis 09]. Useful Homeopathic drugs were identified.
III. Gulabi Bagh TB Center
The Gulabi Bagh TB Center was started in Jan. 2003 to carry out Double blind Placebo Control Study on MDR TB cases along with standard Reserve Line ATT regimen as per the protocol. A total of 210 cases of MDR tuberculosis were studied and already identified useful homoeopathic drugs were used in parallel designed control trial. The reports were discussed in the Scientific Advisory Committee.